What is NDC 69097-974?

69097-974 is the product NDC for Meprobamate, Meprobamate 200 mg/1 tablet, listed with the FDA by Cipla USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Cipla USA Inc., NDC labeler code 69097. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Meprobamate?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Meprobamate NDC 69097-974 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69097-974Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69097-0974Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69097-974-07	6909709740769097097407	100 TABLET in 1 BOTTLE (69097-974-07)Marketed from Jun 7, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Meprobamate
Generic name (nonproprietary): meprobamate
Active ingredients: Meprobamate — 200 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Cipla USA Inc.NDC labeler code 69097
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040797
Marketing start: Jun 7, 2021
Listing expires: Dec 31, 2027
DEA schedule: CIV
Identifiers: Product ID 69097-974_9a6f46ed-9643-4911-9d5e-8175e836c881SPL ID 9a6f46ed-9643-4911-9d5e-8175e836c881SPL set ID 17d814e2-b277-4dce-8615-e7fd7cab773fRxCUI 197928, 197929UNII 9I7LNY769Q

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469097097407 followed by a unit qualifier and the quantity

Package 69097-0974-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 8, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic. The effectiveness of meprobamate tablets in long-term use, that is,more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69097-974

What is NDC 69097-974?: 69097-974 is the product NDC for Meprobamate, Meprobamate 200 mg/1 tablet, listed with the FDA by Cipla USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Meprobamate.
What is the active ingredient?: Meprobamate.
Who is the labeler?: Cipla USA Inc., NDC labeler code 69097. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Meprobamate?: 5 other product NDCs are listed under this name. See all Meprobamate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Meprobamate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Meprobamate	Meprobamate 400 mg/1	TabletOral	Cipla USA Inc.	69097-975	69097-0975-07
Meprobamate	Meprobamate 200 mg/1	TabletOral	Alembic Pharmaceuticals Inc.	62332-019	62332-0019-3062332-0019-3162332-0019-91
Meprobamate	Meprobamate 400 mg/1	TabletOral	Alembic Pharmaceuticals Inc.	62332-020	62332-0020-3062332-0020-3162332-0020-91
Meprobamate	Meprobamate 200 mg/1	TabletOral	Alembic Pharmaceuticals Limited	46708-019	46708-0019-3046708-0019-7146708-0019-91
Meprobamate	Meprobamate 400 mg/1	TabletOral	Alembic Pharmaceuticals Limited	46708-020	46708-0020-3046708-0020-7146708-0020-91

Other NDCs under ANDA 040797

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040797
Product	Strength	Form · route	Labeler	Product NDC
Meprobamate	Meprobamate 400 mg/1	TabletOral	Cipla USA Inc.	69097-975